James V. Cassella
2017
In 2017, James V. Cassella earned a total compensation of $2M as Senior Vice President and Chief Development Officer at Concert Pharmaceuticals, a 78% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $186,965 |
|---|---|
| Option Awards | $523,754 |
| Salary | $406,445 |
| Stock Awards | $832,200 |
| Other | $10,872 |
| Total | $1,960,236 |
Cassella received $832.2K in stock awards, accounting for 42% of the total pay in 2017.
Cassella also received $187K in non-equity incentive plan, $523.8K in option awards, $406.4K in salary and $10.9K in other compensation.
Rankings
In 2017, James V. Cassella's compensation ranked 5,601st out of 14,666 executives tracked by ExecPay. In other words, Cassella earned more than 61.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,601 out of 14,666 | 62nd |
Division Manufacturing | 2,026 out of 5,772 | 65th |
Major group Chemicals And Allied Products | 626 out of 2,075 | 70th |
Industry group Drugs | 482 out of 1,731 | 72nd |
Industry Pharmaceutical Preparations | 378 out of 1,333 | 72nd |
Source: SEC filing on May 3, 2018.
Cassella's colleagues
We found two more compensation records of executives who worked with James V. Cassella at Concert Pharmaceuticals in 2017.